is glp 1 only for people with diabetes GLP-1 receptor agonists are increasingly used to treat type 2 and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal additional benefits of glp 1

Tirzepatide (Zepbound/Mounjaro) is a newer dual-action GIP/GLP-1 agonist that targets two hormonal pathways for even greater results

These findings underscore the potential benefits of combining both molecules for individuals struggling with obesity and related metabolic disorders

Shu Y, He X, Wu P, Liu Y, Ding Y, Zhang Q

(Removed: "immunotherapy") Fraternale A, Paoletti MF, Casabianca A, et al

After reviewing more than 30 products, Healthline writers and sports dietitians Katey Davidson, MScFN, RD, CPT, and Ellen Landes, MS, RDN, CPT, along with our medical vetting team, narrowed down the options to the eight best (plus a few honorable mentions)

doi: 10.3389/fphar.2018.00855 144 XiaC